PIEDMONT INVESTMENT ADVISORS INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 135 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
PIEDMONT INVESTMENT ADVISORS INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$264,000
-54.2%
9,190
+1.1%
0.01%
-50.0%
Q4 2019$576,000
+2642.9%
9,087
+501.4%
0.02%
+1900.0%
Q2 2018$21,0001,5110.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders